|
CA1138436A
(en)
|
1978-02-24 |
1982-12-28 |
Gerhard Baschang |
Process for the manufacture of novel antigens
|
|
JPS5528933A
(en)
|
1978-08-21 |
1980-02-29 |
Dai Ichi Seiyaku Co Ltd |
Muramyldipeptide dimer
|
|
JPS5618996A
(en)
|
1979-06-21 |
1981-02-23 |
Dai Ichi Seiyaku Co Ltd |
Muramyldipeptide derivative
|
|
FI75578C
(fi)
|
1979-07-25 |
1988-07-11 |
Ciba Geigy Ag |
Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
|
|
JPS58172399A
(ja)
|
1982-04-05 |
1983-10-11 |
Dai Ichi Seiyaku Co Ltd |
ムラミルトリペプチド誘導体
|
|
EP0102319B1
(de)
|
1982-07-23 |
1987-08-19 |
Ciba-Geigy Ag |
Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
|
|
FI852105L
(fi)
|
1984-05-29 |
1985-11-30 |
Ciba Geigy Ag |
Acylerade sockerderivat, foerfarande foer deras framstaellning och deras anvaendning.
|
|
JPS6157597A
(ja)
|
1984-08-29 |
1986-03-24 |
Toshiyuki Hamaoka |
ムラミルペプチド活性エステル誘導体
|
|
EP0192611A3
(de)
|
1985-02-20 |
1988-05-11 |
Ciba-Geigy Ag |
Acylierte Hexosederivate und Verfahren zu ihrer Herstellung
|
|
EP0192609A3
(de)
|
1985-02-20 |
1988-04-27 |
Ciba-Geigy Ag |
Acylierte Hexosederivate und Verfahren zu ihrer Herstellung
|
|
US4640911A
(en)
|
1985-05-29 |
1987-02-03 |
Ciba-Geigy Corporation |
Acylated sugar derivatives, processes for their manufacture, and their use
|
|
US5540931A
(en)
|
1989-03-03 |
1996-07-30 |
Charles W. Hewitt |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
|
|
US5549910A
(en)
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
JP3218637B2
(ja)
|
1990-07-26 |
2001-10-15 |
大正製薬株式会社 |
安定なリポソーム水懸濁液
|
|
JP2958076B2
(ja)
|
1990-08-27 |
1999-10-06 |
株式会社ビタミン研究所 |
遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
|
|
US5506204A
(en)
|
1991-11-19 |
1996-04-09 |
Peptech (Uk) Limited |
Muramyl compounds for treatment of septic shock
|
|
GB9221220D0
(en)
|
1992-10-09 |
1992-11-25 |
Sandoz Ag |
Organic componds
|
|
US5349060A
(en)
|
1993-01-07 |
1994-09-20 |
American Home Products Corporation |
Rapamycin 31-ester with N,N-dimethylglycine derivatives useful as immunosuppressive agents
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
GB9320820D0
(en)
|
1993-10-08 |
1993-12-01 |
Biokine Tech Ltd |
Compounds for medicinal use
|
|
SK78196A3
(en)
|
1993-12-17 |
1997-02-05 |
Sandoz Ag |
Rapamycin demethoxy-derivatives, preparation method thereof and pharmaceutical agent containing them
|
|
US5741516A
(en)
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
|
GB9413935D0
(en)
|
1994-07-11 |
1994-08-31 |
Peptech Uk Ltd |
Use of maramyl peptide compounds
|
|
GB9419011D0
(en)
|
1994-09-21 |
1994-11-09 |
Peptech Uk Ltd |
Use of muramyl peptide compounds
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5985890A
(en)
|
1995-06-09 |
1999-11-16 |
Novartis Ag |
Rapamycin derivatives
|
|
US5738868A
(en)
|
1995-07-18 |
1998-04-14 |
Lipogenics Ltd. |
Liposome compositions and kits therefor
|
|
GB9618673D0
(en)
|
1996-09-06 |
1996-10-16 |
Peptech Uk Ltd |
The use of muramyl peptides
|
|
CA2407897A1
(en)
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
|
CA2319928A1
(en)
|
2000-09-18 |
2002-03-18 |
Vasogen Ireland Limited |
Apoptosis-mimicking synthetic entities and use thereof in medical treatments
|
|
GB0025414D0
(en)
|
2000-10-16 |
2000-11-29 |
Consejo Superior Investigacion |
Nanoparticles
|
|
US7592008B2
(en)
|
2000-11-20 |
2009-09-22 |
The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois |
Membrane scaffold proteins
|
|
CA2466279A1
(en)
|
2001-11-13 |
2003-05-22 |
Dana-Farber Cancer Institute, Inc. |
Agents that modulate immune cell activation and methods of use thereof
|
|
CN101899114A
(zh)
|
2002-12-23 |
2010-12-01 |
惠氏公司 |
抗pd-1抗体及其用途
|
|
AU2004224761A1
(en)
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
HIV-peptide-carrier-conjugates
|
|
MXPA06006738A
(es)
|
2003-12-19 |
2006-08-31 |
Univ North Carolina |
Metodos para fabricar micro- y nano-estructuras aisladas utilizando litografia suave o de impresion.
|
|
JP4224115B2
(ja)
|
2004-04-14 |
2009-02-12 |
ワイス |
ラパマイシン４２−エステル誘導体の位置特異的合成
|
|
KR100560102B1
(ko)
|
2004-06-25 |
2006-03-13 |
한국생명공학연구원 |
프로아포리포단백질 ａ－ⅰ 변이체와, 이를 포함하는고지혈증 또는 동맥경화증 예방 및 치료제
|
|
WO2006080951A2
(en)
|
2004-07-01 |
2006-08-03 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
DK2439273T3
(da)
|
2005-05-09 |
2019-06-03 |
Ono Pharmaceutical Co |
Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
|
|
PT1907424E
(pt)
|
2005-07-01 |
2015-10-09 |
Squibb & Sons Llc |
Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1)
|
|
JP2009504192A
(ja)
|
2005-08-19 |
2009-02-05 |
サイリーン ファーマシューティカルズ インコーポレーティッド |
ヒトリボソームＤＮＡ（ｒＤＮＡ）およびリボソームＲＮＡ（ｒＲＮＡ）核酸ならびにそれらの使用
|
|
CA2683063A1
(en)
|
2007-04-09 |
2008-10-16 |
Chimeros, Inc. |
Self-assembling nanoparticle drug delivery system
|
|
CN101096386A
(zh)
|
2007-06-05 |
2008-01-02 |
复旦大学 |
Dectin-1与热休克蛋白Hsp60聚合物及其编码核酸和应用
|
|
BR122017025062B8
(pt)
|
2007-06-18 |
2021-07-27 |
Merck Sharp & Dohme |
anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento
|
|
US7928100B2
(en)
|
2007-10-05 |
2011-04-19 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs and methods related thereto
|
|
JP2011500569A
(ja)
|
2007-10-12 |
2011-01-06 |
マサチューセッツ インスティテュート オブ テクノロジー |
ワクチンナノテクノロジー
|
|
EP2217221B1
(en)
|
2007-10-17 |
2018-06-27 |
Korea Advanced Institute of Science and Technology |
Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same
|
|
CN105903029A
(zh)
|
2007-12-12 |
2016-08-31 |
大学健康网络 |
高密度脂蛋白样肽磷脂支架（“hpps”）纳米颗粒
|
|
WO2009106999A2
(en)
|
2008-02-28 |
2009-09-03 |
Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts |
Hollow nanoparticles and uses thereof
|
|
EP2262837A4
(en)
|
2008-03-12 |
2011-04-06 |
Merck Sharp & Dohme |
PD-1 BINDING PROTEINS
|
|
US8268796B2
(en)
|
2008-06-27 |
2012-09-18 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use thereof
|
|
US8552154B2
(en)
|
2008-09-26 |
2013-10-08 |
Emory University |
Anti-PD-L1 antibodies and uses therefor
|
|
CN102264364B
(zh)
*
|
2008-10-22 |
2014-06-18 |
康奈尔大学 |
一种多环化合物及其相关方法
|
|
US20120015899A1
(en)
|
2008-10-25 |
2012-01-19 |
Plant Bioscience, Limited |
Modified plant virus particles and uses therefor
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
JP5844159B2
(ja)
|
2009-02-09 |
2016-01-13 |
ユニヴェルシテ デクス−マルセイユＵｎｉｖｅｒｓｉｔｅ Ｄ’Ａｉｘ−Ｍａｒｓｅｉｌｌｅ |
Ｐｄ−１抗体およびｐｄ−ｌ１抗体ならびにその使用
|
|
US10525152B2
(en)
|
2009-10-09 |
2020-01-07 |
Signablok, Inc. |
Methods and compositions for targeted imaging
|
|
WO2011066342A2
(en)
|
2009-11-24 |
2011-06-03 |
Amplimmune, Inc. |
Simultaneous inhibition of pd-l1/pd-l2
|
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
|
WO2011159877A2
(en)
|
2010-06-18 |
2011-12-22 |
The Brigham And Women's Hospital, Inc. |
Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions
|
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
|
EP2620156B1
(en)
|
2010-08-23 |
2019-03-27 |
Kang Stem Biotech Co., Ltd. |
Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof
|
|
KR101253399B1
(ko)
|
2010-10-26 |
2013-04-11 |
영남대학교 산학협력단 |
아포지단백질 ａ－ｉ 및 그 변이체를 포함한 재조합 고밀도지단백질을 이용한 라파마이신 제형
|
|
US20140086839A1
(en)
|
2011-03-17 |
2014-03-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
|
CN102178954B
(zh)
|
2011-04-25 |
2014-05-28 |
中国药科大学 |
具有血管壁靶向和逆向转运胆固醇功能的重组高密度脂蛋白载药系统及其应用
|
|
WO2013143555A1
(en)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Rna formulation for immunotherapy
|
|
WO2013192310A1
(en)
|
2012-06-19 |
2013-12-27 |
Massachusetts Institute Of Technology |
Mass production and size control of nanoparticles through controlled microvortices
|
|
EP2703384A1
(en)
|
2012-08-27 |
2014-03-05 |
Ludwig-Maximilians-Universität München |
Inhibitors of CD40-TRAF6 interaction
|
|
IL292510A
(en)
|
2013-11-05 |
2022-06-01 |
Cognate Bioservices Inc |
Combinations of checkpoint inhibitors and therapeutics to treat cancer
|
|
CN103589699B
(zh)
*
|
2013-11-05 |
2015-05-13 |
江南大学 |
一种可溶性淀粉底物特异性提高的环糊精糖基转移酶
|
|
ES2754207T3
(es)
|
2013-11-28 |
2020-04-16 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Inhibidores de la ARN polimerasa I y usos de los mismos
|
|
PL4023249T3
(pl)
|
2014-04-23 |
2025-03-10 |
Modernatx, Inc. |
Szczepionki z kwasem nukleinowym
|
|
WO2016019333A1
(en)
|
2014-07-31 |
2016-02-04 |
Kinemed, Inc. |
The effect of phospholipid composition of reconstituted hdl on its cholesterol efflux and anti-inflammatory properties
|
|
US10610564B2
(en)
|
2015-02-26 |
2020-04-07 |
Stc.Unm |
IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
|
|
JP2018516847A
(ja)
|
2015-03-25 |
2018-06-28 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
生体高分子薬を送達するための組成物及び方法
|
|
US11642419B2
(en)
|
2015-03-25 |
2023-05-09 |
The Regents Of The University Of Michigan |
Compositions and methods for treating cardiovascular related disorders
|
|
WO2016155809A1
(en)
|
2015-03-31 |
2016-10-06 |
Biontech Rna Pharmaceuticals Gmbh |
Lipid particle formulations for delivery of rna and water-soluble therapeutically effective compounds to a target cell
|
|
ES2819473T3
(es)
|
2015-04-20 |
2021-04-16 |
Memorial Sloan Kettering Cancer Center |
Obtención de imágenes de macrófagos asociados a tumor
|
|
US10995140B2
(en)
|
2015-06-05 |
2021-05-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapy
|
|
BR112018000217A2
(pt)
|
2015-07-15 |
2018-09-04 |
Celator Pharmaceuticals Inc |
sistemas de distribuição de nanopartículas aperfeiçoados
|
|
US20180221289A1
(en)
|
2015-08-06 |
2018-08-09 |
Autotelic Llc |
Phospholipid-cholesteryl ester nanoformulations and related methods
|
|
US20190008918A1
(en)
|
2016-03-08 |
2019-01-10 |
Bioxcel Corporation |
Immunomodulation therapies for cancer
|
|
CN109640959B
(zh)
*
|
2016-04-29 |
2023-03-17 |
西奈山伊坎医学院 |
靶向先天免疫系统以诱导长期耐受性及解决动脉粥样硬化中的巨噬细胞累积
|
|
EP3464270B1
(en)
*
|
2016-05-24 |
2022-02-23 |
Genentech, Inc. |
Heterocyclic inhibitors of cbp/ep300 and their use in the treatment of cancer
|
|
WO2018071549A1
(en)
|
2016-10-11 |
2018-04-19 |
New York University |
Nanoparticles and uses thereof
|
|
CN106831614B
(zh)
*
|
2017-01-09 |
2020-07-28 |
清华大学 |
取代的苯并二氮杂环类化合物及其制备方法和用途
|
|
WO2018187515A1
(en)
|
2017-04-04 |
2018-10-11 |
Avidea Technologies, Inc. |
Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
|
|
AU2018370237B2
(en)
|
2017-11-20 |
2024-10-17 |
Icahn School Of Medicine At Mount Sinai |
Inhibiting trained immunity with a therapeutic nanobilogic composition
|
|
EP3713548A4
(en)
|
2017-11-21 |
2021-06-23 |
Icahn School of Medicine at Mount Sinai |
Promoting trained immunity with therapeutic nanobiologic compositions
|